Kingsview Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Kingsview Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $393,205 - $442,356	1,376 New	1,376 $397,000
Q2 2022 Aug 16, 2022	SELL	$234.96 - $292.55 $55,920 - $69,626	-238 Reduced 8.7%	2,499 $704,000
Q1 2022 Feb 08, 2024	BUY	$221.42 - $260.97 $584,105 - $688,438	2,638 New	2,638 $688,000
Q4 2021 Feb 17, 2022	SELL	$177.01 - $223.45 $24,781 - $31,283	-140 Reduced 4.87%	2,737 $601,000
Q3 2021 Dec 03, 2021	SELL	$181.39 - $202.99 $6,348 - $7,104	-35 Reduced 1.2%	2,877 $522,000
Q2 2021 Aug 17, 2021	BUY	$187.49 - $221.1 $14,624 - $17,245	78 Added 2.75%	2,912 $589,000
Q1 2021 May 24, 2021	SELL	$207.02 - $241.31 $182,384 - $212,594	-881 Reduced 23.71%	2,834 $604,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $265,179 - $353,671	1,281 Added 52.63%	3,715 $878,000
Q3 2020 Nov 19, 2020	BUY	$255.65 - $303.1 $622,252 - $737,745	2,434 New	2,434 $662,000

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.